HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 17 February 2006. doi:10.1136/hrt.2005.068296
Heart 2007;93:665-671
Copyright © 2007 BMJ Publishing Group Ltd & British Cardiovascular Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow web only appendix
Right arrow All Versions of this Article:
hrt.2005.068296v1
93/6/665    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lang, C. C
Right arrow Articles by Mancini, D. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, C. C
Right arrow Articles by Mancini, D. M

HEART REVIEW

Non-cardiac comorbidities in chronic heart failure

Chim C Lang1, Donna M Mancini2

1 Department of Cardiology, Ninewells Hospital and Medical School, Dundee, UK
2 Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA

Correspondence to:
Correspondence to:
Professor C C Lang
Department of Cardiology, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK;c.c.lang{at}dundee.ac.uk


ABSTRACT
Non-cardiac comorbidity complicates heart failure care and is prevalent in one form or another for the majority of elderly patients with heart failure. This wide range of comorbidities, which includes respiratory comorbidities, renal dysfunction, anaemia, arthritis, cognitive dysfunction and depression, contributes to the progression of the disease and may alter the response to treatment. Polypharmacy is inevitable in these patients. Cardiologists and other physicians caring for patients with chronic heart failure (CHF) need to be vigilant to comorbid conditions that may complicate the care of these patients. Future trials should focus on optimal strategies for the comprehensive management of the elderly patients with CHF with multiple comorbidities rather than the isolated effects of single drugs in younger patients with few or no comorbidities.


Abbreviations: BNP, brain natriuretic peptide; CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; CSA, central sleep apnoea; HF, heart failure; NYHA, New York Heart Association; OSA, obstructive sleep apnoea; rHuEPO, recombinant human erythropoietin; SDB, sleep-disordered breathing; TNF, tumour necrosis factor







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & British Cardiovascular Society